Jeannie K Lee

Summary

Affiliation: University of Arizona
Country: USA

Publications

  1. pmc Ten lessons learned from conducting an adherence intervention trial
    Jeannie K Lee
    College of Pharmacy, University of Arizona, Tucson, AZ, USA
    Patient Prefer Adherence 3:93-8. 2009
  2. doi Cost-effectiveness of biological agents used in ulcerative colitis
    Jeannie K Lee
    Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, 1295 N Martin Ave, Tucson, AZ 85721 0202, USA Section of Geriatrics, Internal Medicine and Palliative Medicine, University of Arizona College of Medicine, 1295 N Martin Ave, Tucson, AZ 85721 0202, USA Electronic address
    Best Pract Res Clin Gastroenterol 27:949-60. 2013
  3. doi Geriatric patient care by U.S. pharmacists in healthcare teams: systematic review and meta-analyses
    Jeannie K Lee
    Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA
    J Am Geriatr Soc 61:1119-27. 2013
  4. doi A systematic review of economic studies on biological agents used to treat Crohn's disease
    Derek H Tang
    Department of Pharmaceutical Sciences and Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, Tucson, Arizona and Division of Gastroenterology, Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona
    Inflamm Bowel Dis 19:2673-94. 2013
  5. doi Health outcomes and cost-effectiveness of certolizumab pegol in the treatment of Crohn's disease
    Jill M Augustine
    University of Arizona College of Pharmacy, 1295 N Martin Ave Tucson, AZ 85721 0202, USA
    Expert Rev Pharmacoecon Outcomes Res 14:599-609. 2014
  6. doi Cost-utility analysis of biologic treatments for moderate-to-severe Crohn's disease
    Derek H Tang
    Department of Pharmaceutical Sciences, University of Arizona College of Pharmacy, Tucson, AZ 85721, USA
    Pharmacotherapy 32:515-26. 2012
  7. ncbi Aging: Is your patient taking too many pills?
    Barry D Weiss
    Arizona Center on Aging, Department of Family and Community Medicine, University of Arizona College of Medicine, Tucson, AZ, USA
    J Fam Pract 61:652-61. 2012

Collaborators

Detail Information

Publications7

  1. pmc Ten lessons learned from conducting an adherence intervention trial
    Jeannie K Lee
    College of Pharmacy, University of Arizona, Tucson, AZ, USA
    Patient Prefer Adherence 3:93-8. 2009
    ....
  2. doi Cost-effectiveness of biological agents used in ulcerative colitis
    Jeannie K Lee
    Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, 1295 N Martin Ave, Tucson, AZ 85721 0202, USA Section of Geriatrics, Internal Medicine and Palliative Medicine, University of Arizona College of Medicine, 1295 N Martin Ave, Tucson, AZ 85721 0202, USA Electronic address
    Best Pract Res Clin Gastroenterol 27:949-60. 2013
    ..However the dose, duration, and effectiveness of biological treatments significantly impact estimates of their cost-effectiveness...
  3. doi Geriatric patient care by U.S. pharmacists in healthcare teams: systematic review and meta-analyses
    Jeannie K Lee
    Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA
    J Am Geriatr Soc 61:1119-27. 2013
    ..To conduct a systematic review and meta-analyses to examine the effects of pharmacists' care on geriatric patient-oriented health outcomes in the United States (U.S.)...
  4. doi A systematic review of economic studies on biological agents used to treat Crohn's disease
    Derek H Tang
    Department of Pharmaceutical Sciences and Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, Tucson, Arizona and Division of Gastroenterology, Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona
    Inflamm Bowel Dis 19:2673-94. 2013
    ..Identifying clinical scenarios that maximize the cost-effectiveness of biological treatments can lead to optimized health care cost-saving and clinical effectiveness from a society's perspective...
  5. doi Health outcomes and cost-effectiveness of certolizumab pegol in the treatment of Crohn's disease
    Jill M Augustine
    University of Arizona College of Pharmacy, 1295 N Martin Ave Tucson, AZ 85721 0202, USA
    Expert Rev Pharmacoecon Outcomes Res 14:599-609. 2014
    ..Considering subcutaneous self-administration, and lower number and frequency of injections, patients may prefer certolizumab pegol over the other biological treatments. ..
  6. doi Cost-utility analysis of biologic treatments for moderate-to-severe Crohn's disease
    Derek H Tang
    Department of Pharmaceutical Sciences, University of Arizona College of Pharmacy, Tucson, AZ 85721, USA
    Pharmacotherapy 32:515-26. 2012
    ..To compare the cost versus utility of four guideline-recommended biologic treatments-infliximab, adalimumab, certolizumab pegol, and natalizumab-for the treatment of Crohn's disease from a United States payer perspective...
  7. ncbi Aging: Is your patient taking too many pills?
    Barry D Weiss
    Arizona Center on Aging, Department of Family and Community Medicine, University of Arizona College of Medicine, Tucson, AZ, USA
    J Fam Pract 61:652-61. 2012
    ..Before you prescribe another drug, consider whether new symptoms might be caused by the medications the patient is already taking...